Sulfasalazine plus Chloroquine-Induced Mood Disorder in a Patient with Rheumatoid Arthritis

Gulec, Gulcan; Yenilmez, Cinar; Ayranci, Unal
March 2009
Iranian Journal of Medical Sciences;Mar2009, Vol. 34 Issue 1, p72
Academic Journal
Rheumatoid arthritis is a chronic systemic inflammatory disease that affects approximately 0.5-1% of the world population. The current approach to this disease is to start an intensive treatment without delay once the disease has developed. Various studies in the literature have shown that combination of disease modifying antirheumatic drugs such as sulfasalazine and chloroquine offers a more advantageous treatment. Although these drugs may cause central nervous system adverse effects such as serious psychiatric problems including mania and psychosis, these symptoms have been reported to occur only infrequently. The present case study reports a female patient who was hospitalized due to bipolar affective disorder- mixed episode. She had been receiving 250 mg/day chloroquine for 9 months for rheumatoid arthritis without exhibiting any adverse psychiatric effects. However, upon receiving a combination of 250 mg/day chloroquine and 2 gr/day sulfasalazine, she developed serious psychiatric symptoms.


Related Articles

  • Specificity of psychosis, mania and major depression in a contemporary family study. Vandeleur, C L; Merikangas, K R; Strippoli, M-P F; Castelao, E; Preisig, M // Molecular Psychiatry;Feb2014, Vol. 19 Issue 2, p209 

    There has been increasing attention to the subgroups of mood disorders and their boundaries with other mental disorders, particularly psychoses. The goals of the present paper were (1) to assess the familial aggregation and co-aggregation patterns of the full spectrum of mood disorders (that is,...

  • Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain. Tafalla, Monica; Salvador-Carulla, Luis; Saiz-Ruiz, Jerónimo; Diez, Teresa; Cordero, Luis // BMC Psychiatry;2010, Vol. 10, p31 

    Background: Although some studies indicate that bipolar disorder causes high health care resources consumption, no study is available addressing a cost estimation of bipolar disorder in Spain. The aim of this observational study was to evaluate healthcare resource utilization and the associated...

  • Fenomenolog�a del trastorno bipolar con ciclos r�pidos: datos de los primeros 500 participantes del Systematic Treatment Enhancement Program. Schneck, Christopher D.; Miklowitz, David J.; Calabrese, Joseph R.; Allen, Michael H.; Thomas, Marshall R.; Wisniewski, Stephen R.; Miyahara, Sachiko; Shelton, Melvin D.; Ketter, Terence A.; Goldberg, Joseph F.; Bowden, Charles L.; Sachs, Gary S. // American Journal of Psychiatry - Edici�n Espa�ola;Jan2005, Vol. 8 Issue 1, p54 

    No abstract available.

  • Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. McTavish, S. F. B.; McPherson, M. H.; Harmer, C. J.; Clark, L.; Sharp, T.; Goodwin, G. M.; Cowen, P. J. // British Journal of Psychiatry;Oct2001, Vol. 179, p356 

    Background In rats, amino acid mixtures lacking tyrosine and its precursor phenylalanine decrease the release of dopamine produced by the psychostimulant drug amphetamine. Amphetamine has been proposed as a model for clinical mania. Aims To assess whether dietary tyrosine depletion attenuates...

  • A Case of Recurrent Mania with Recurrent Hyperthyroidism. Corn, Timothy H.; Checkley, Stuart A. // British Journal of Psychiatry;Jul83, Vol. 143, p74 

    The article presents a case report of recurrent mania with recurrent hyerperthyroidism in a Jewish female who has a family history of thyroid disorder. The probability of two relatively common illnesses occurring together by chance is not small and this case cannot be interpreted as suggesting a...

  • The Performance of Manic Patients on the 'Grid Test for Schizophrenic Thought Disorder'. Mellsop, G. W.; Spelman, M. S.; Harrison, A. W. // British Journal of Psychiatry;Jun71, Vol. 118 Issue 547, p671 

    The article discusses the comparative study concerning the performance of manic patients and thought-process-disordered schizophrenics on the Grid Test for schizophrenic thought disorder. The test was administered by twelve patients and twenty-four schizophrenics with thought-process disorder....

  • Twin study of symptom dimensions in psychoses. Cardno, Alastair G.; Sham, Pak C.; Murray, Robin M.; McGuffin, Peter // British Journal of Psychiatry;Jul2001, Vol. 179, p39 

    Background Symptomatology in psychoses can be summarised as quantitative symptom dimensions, but their genetic basis is unknown. Aims To investigate whether genes make an important contribution to symptom dimensions. Method A total of 224 probandwise twin pairs (106 monozygotic, 118 same-gender...

  • Ziprasidone.  // Reactions Weekly;11/29/2008, Issue 1230, p35 

    The article describes the case of a 28-year-old man with schizophrenia who developed mania following initiation of treatment with ziprasidone. He was instead treated with lithium and quetiapine. After doing so, his Young Mania Rating Scale (YMRS) decreased to 0 by day 36, experiencing no further...

  • Distribution of symptom dimensions across Kraepelinian divisions. Dikeos, Dimitris G.; Wickham, Harvey; McDonald, Colm; Walshe, Muriel; Sigmundsson, Thordur; Bramon, Elvira; Grech, Anton; Toulopoulou, Timothea; Murray, Robin; Sham, Pak C. // British Journal of Psychiatry;Oct2006, Vol. 189, p346 

    Background: Dimensional structures are established for many psychiatric diagnoses, but dimensions have not been compared between diagnostic groups.Aims: To examine the structure of dimensions in psychosis, to analyse their correlations with disease characteristics and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics